Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001234486 | SCV001407136 | pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2023-04-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 960879). This variant has not been reported in the literature in individuals affected with ACADM-related conditions. This variant is present in population databases (rs772650083, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Tyr201Ilefs*38) in the ACADM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACADM are known to be pathogenic (PMID: 16121256, 20434380). |
Fulgent Genetics, |
RCV001234486 | SCV002810307 | likely pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2022-03-20 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001234486 | SCV004213974 | likely pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2024-03-17 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001234486 | SCV004238411 | likely pathogenic | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2023-02-17 | criteria provided, single submitter | clinical testing |